Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

Clinical trial NCT01932437 · COMPLETED

Trial details

NCT number: NCT01932437
Sponsor: Elusys Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inhalational Anthrax

Start date: 2013-07-26
Primary completion: 2014-07-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.